← All trials
NCT01835223
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 11, 2013
- Primary completion
- May 16, 2017
- Completion date
- Aug 14, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 21
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- State University of New York, BuffaloLead sponsor
- National Cancer Institute (NCI)Collaborator
- National Comprehensive Cancer NetworkCollaborator
- AVEO PharmaceuticalsCollaborator
- State University of New York, BuffaloOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.